Stocks and Investing
Stocks and Investing
Wed, March 13, 2024
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
Tue, March 12, 2024
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
Derek Archila Maintained (ZYME) at Buy with Increased Target to $14 on, Mar 12th, 2024
Derek Archila of Wells Fargo, Maintained "Zymeworks Inc." (ZYME) at Buy with Increased Target from $12 to $14 on, Mar 12th, 2024.
Derek has made no other calls on ZYME in the last 4 months.
There is 1 other peer that has a rating on ZYME. Out of the 1 peers that are also analyzing ZYME, all agrees with Derek's Rating of Hold. Following is the relevant analyst calls for the last 4 months
- Robert Burns of "HC Wainwright & Co." Maintained at Hold with Increased Target to $10 on, Monday, March 11th, 2024
Contributing Sources